US2022306663A1PendingUtilityA1
Metal Tricarbonyl Complexes Comprising Substituted Iminodiactic Acid Ligands and Uses as Radioisotope Tracers
Est. expiryMar 10, 2035(~8.6 yrs left)· nominal 20-yr term from priority
C07F 13/00G01N 2800/347A61K 51/0478C07B 59/004A61K 51/0402A61B 6/4057G01N 33/5088G01N 33/60
71
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
This disclosure relates to compositions comprising substituted iminodiacetic acid ligands and metal tricarbonyl complexes containing the ligands and derivatives thereof. In certain embodiments, the metal tricarbonyl complexes are used as radioisotope tracers such as renal tracers. In certain embodiments, the metal complexes comprise 99m Tc or Re. In certain embodiments, the ligands are substituted with a fluorine, a fluorine-18(F 18 ) radioisotope, or other radionuclide.
Claims
exact text as granted — not AI-modified1 . An imaging method comprising injecting into a human a tricarbonyl complex having the formula Re(CO) 3 (N-(2- 18 fluoroethyl)iminodiacetate and imaging the 18 F analog.
2 . The method of claim 1 , wherein the imaging is renal imaging.
3 . An imaging method comprising injecting into a human a tricarbonyl complex having formula 99m Tc(CO) 3 (N-(2-fluoroethyl)iminodiacetate) and imaging the 99m Tc analog.
4 . The method of claim 3 , wherein the imaging is renal imaging.
5 . An imaging method comprising injecting into a human a tricarbonyl complex having the formula Re(CO) 3 (N-(2- 18 fluoroethyl)iminodiacetate and the formula 99m Tc(CO) 3 (N-(2-fluoroethyl)iminodiacetate) and imaging the 18 F analog and 99m Tc analog.
6 . The method of claim 5 , wherein the imaging is renal imaging.Join the waitlist — get patent alerts
Track US2022306663A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.